ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.60
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.395
0.41%
Bitcoin
57,791.33
0.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
01/20/202212:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/20221:14PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/20221:02PMDow Jones NewsUnilever ADRs Bounce Back After Co. Commits to Financial DisciplineNYSE:GSKGSK plc
01/19/20221:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/202212:15PMDow Jones NewsUnilever Says It Won't Raise Offer for GSK Consumer Health DivisionNYSE:GSKGSK plc
01/19/202211:34AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/20227:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/20222:47AMDow Jones NewsGlaxoSmithKline Names Tony Wood CSO DesignateNYSE:GSKGSK plc
01/18/20228:34AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/18/20226:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/14/20221:09PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/13/20229:02AMGlobeNewswire Inc.GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19NYSE:GSKGSK plc
01/11/202212:08PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/11/20228:10AMDow Jones NewsGSK, Vir Say U.S. to Buy Added Supply of Covid TreatmentNYSE:GSKGSK plc
01/11/20227:42AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/11/20227:12AMGlobeNewswire Inc.GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized for the Early Treatment of COVID-19NYSE:GSKGSK plc
01/06/20222:27PMPR Newswire (Canada)GSK annonce d'autres conventions d'achat conclues avec le gouvernement du Canada concernant un traitement par anticorps monoclonal anti-COVID-19, le sotrovimabNYSE:GSKGSK plc
01/06/20222:20PMPR Newswire (Canada)GSK announces additional purchase agreements with the Government of Canada for COVID-19 monoclonal antibody therapy, SotrovimabNYSE:GSKGSK plc
01/04/20228:57AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/23/20218:52AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/22/202111:56AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/21/20217:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/21/20212:48AMDow Jones NewsGlaxoSmithKline: HIV Drug Apretude Approved in US by FDANYSE:GSKGSK plc
12/20/20215:14PMDow Jones NewsGlaxoSmithKline Unit Viiv Gets FDA Approval for First Injectable Treatment for HIV Pre-Exposure PreventionNYSE:GSKGSK plc
12/17/20218:34AMDow Jones NewsGlaxoSmithKline, Vir Covid-19 Treatment Gets EU ApprovalNYSE:GSKGSK plc
12/17/20218:16AMGlobeNewswire Inc.Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19NYSE:GSKGSK plc
12/15/20216:20AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/15/20212:25AMDow Jones NewsSanofi, GlaxoSmithKline Share Positive Preliminary Booster Data for Covid-19 Vaccine CandidateNYSE:GSKGSK plc
12/13/20219:34AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/13/20217:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
AMEX
SPY
SPDR S&P 500
NASDAQ
AMRN
Amarin
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved